UV safety month poll: Have you treated UV-related eye conditions this year?

Poll

A poll for ophthalmologists and retina specialists to celebrate UV Safety Month. This poll will close July 28, 2021.

UV safety month poll: Have you treated UV-related eye conditions this year?

July is UV Safety Month, and we want to ask retina specialists and ophthalmologists about their experiences with UV eye damage in 2021.

[@portabletext/react] Unknown block type "pollMultiChoice", specify a component for it in the `components.types` prop
Recent Videos
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
Related Content
NIH announces elements of brain-based visual impairment in children

NIH announces elements of brain-based visual impairment in children

Lynda Charters
November 22nd 2024
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
December 1st 2020
Podcast
Harrow to reduce prices and partner with GoodRx

Harrow to reduce prices and partner with GoodRx

Sydney M Crago
November 22nd 2024
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
November 5th 2020
Podcast
Cencora to acquire Retina Consultants of America for up to $5.1 Billion

Cencora to acquire Retina Consultants of America for up to $5.1 Billion

Sydney M Crago
November 12th 2024
Article
OSN New York Retina meeting to highlight geographic atrophy and diabetic eye conditions

OSN New York Retina meeting to highlight geographic atrophy and diabetic eye conditions

Sydney M Crago
November 7th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.